**Education and Professional Experience:** **Education:** 1. 1981/09 - 1987/07, Sun Yat-sen University of Medical Sciences (Clinical Medicine), Bachelor's Degree 2. 1994/09 - 1997/12, Sun Yat-sen University of Medical Sciences (Oncology), Master's Degree **Professional Experience:** 1. 1987/07 - 1994/11, Sun Yat-sen University Cancer Center / Department of Radiation Oncology, Resident Physician 2. 1994/11 - 2002/01, Sun Yat-sen University Cancer Center / Department of Radiation Oncology, Attending Physician 3. 2002/01 - 2014/12, Sun Yat-sen University Cancer Center / Department of Radiation Oncology, Associate Chief Physician, concurrently serving as Head of the Radiation Oncology Outpatient Area 4. 2014/12 - 2017/05, Sun Yat-sen University Cancer Center / Department of Radiation Oncology, Chief Physician, concurrently serving as Head of the Radiation Oncology Outpatient Area 5. 2017/05 - Present, The First Affiliated Hospital, Sun Yat-sen University / Department of Radiation Oncology, Chief Physician, Department Director **Social Appointments:** Standing Committee Member, Radiation Therapy Physician Branch, Guangdong Medical Doctor Association **Publications (SCI, First Author/Corresponding Author):** (1) Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial. *Scientific Reports*. (IF=5.578) (2) Development and external validation of nomograms for predicting survival in nasopharyngeal carcinoma patients after definitive radiotherapy. *Scientific Reports*. (IF=5.578) (3) Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. *Cancer*. (IF=4.889) (4) Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. *International Journal of Radiation Oncology, Biology, Physics*. (IF=4.258) (5) Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC. *Tumor Biology*. (IF=3.611) (6) Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy? *BMC Cancer*. (IF=3.362) (7) Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma. *BMC Cancer*. (IF=3.362) (8) Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study. *BMC Cancer*. (IF=3.362) (9) Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy. *Radiation Oncology*. (IF=2.546) (10) Spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma and salivary gland-type carcinomas. *Clinical Otolaryngology*. (IF=2.113)